Belle's public pricing is organized by subscription length, not dose tier. As of September 2026, no published policy confirms whether Belle raises prices when a patient's semaglutide or tirzepatide dose is titrated up.

Hims & Hers advertises compounded semaglutide at $199/month when you prepay $1,194 for six months. We compare that commitment against month-to-month alternatives and show the 12-month math.

Noom Med charges $129/month for its Core Med program after the first month, billed quarterly—but medication is priced separately. The microdose program has an introductory rate followed by a higher ongoing subscription cost.